Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Frost & Sullivan Publishes Q1 2019 Update on Oramed Pharmaceuticals Inc.
2019-02-14 03:01
Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States
2019-02-13 20:30
Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing
2019-02-13 08:00
Frost & Sullivan Publishes Immediate Report on BiolineRx
2019-02-13 01:17
GC Pharma Reports Full Year 2018 Results
2019-02-12 22:00
WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership
2019-02-12 08:04
Bridge Biotherapeutics Presented Preclinical and Phase I Study Results for BBT-401 at the Crohn's & Colitis Congress
2019-02-11 22:00
3SBio and Verseau Establish Global Clinical Development Collaboration for First-in-class Immuno-Oncology Therapies
2019-02-11 20:19
3SBio and Verseau Establish Global Clinical Development Collaboration for First-in-class Immuno-Oncology Therapies
2019-02-11 20:18
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare
2019-02-11 18:30
CStone and IMPACT Therapeutics' clinical collaboration progresses to IND filing acceptance for CS1001+IMP4297 combination therapy
2019-02-08 03:10
BioLineRx Announces Closing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
2019-02-08 02:42
Innovent Receives IND Approval of a Bispecific Antibody (IBI318) by the NMPA
2019-02-07 22:37
NanoRacks Senior Leaders Speak in Japan at JAXA International Space Station "Kibo" Utilization Symposium
2019-02-07 08:30
BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
2019-02-06 00:40
Primex Pharmaceuticals appoints Alan Knox as Group CEO
2019-02-06 00:14
Taiho Pharmaceutical and Cullinan Oncology Establish Collaboration to Develop TAS6417, Novel EGFR Tyrosine Kinase Inhibitor
2019-02-05 16:00
GeneQuantum Healthcare and MITRO Biotech Enter into Strategic Cooperation to Develop Next Generation Radionuclide Conjugates
2019-02-03 20:00
I-Mab Biopharma and Bio-Cancer Treatment International Announce Intention for Collaboration on Arginine Depletion Therapy and Biomarker Study, with Plans for I-Mab to Establish a Translational Medicine Lab in Hong Kong
2019-02-01 17:46
TOLSURA (TM) (SUBA®-itraconazole) Antifungal Capsule Now Available in the United States
2019-01-30 20:30
1
325
326
327
328
329
401